Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
mistake (35)
,
fault (22)
,
slip (31)
Docetaxel (100) Ver 1.1
Description
Chemotherapy Protocol BREAST CANCER Regimen DOCETAXEL (100) Breast Cancer – Docetaxel (100) Indication Neoadjuvant / adjuvant treatment of breast cancer WHO Performance status
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-100-Ver-11.pdf
Cyclophosphamide-Doxorubicin-Paclitaxel
Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN-PACLITAXEL (21 day) Regimen • Breast Cancer – Cyclophosphamide-Doxorubicin-Paclitaxel (21 day) Indication • Neoadjuvant / adjuvant therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Paclitaxel.pdf
Cyclophosphamide-Docetaxel-Epirubicin (100)-Fluorouracil (FE100CT)
Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-EPIRUBICIN (100)- FLUOROURACIL Regimen (FE100CT) • Breast Cancer – Cyclophosphamide-Docetaxel-Epirubicin (100)-Fluorouracil (FE100CT) Indication • Neo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Docetaxel-Epirubicin-100-Fluorouracil.pdf
Cyclophosphamide-Docetaxel-Doxorubicin Ver 1.1
Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-DOXORUBICIN Regimen (TAC) Breast Cancer – Cyclophosphamide-Docetaxel-Doxorubicin (TAC) Indication Adjuvant therapy for node positive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelDoxorubicinTACVer11.pdf
Cyclophosphamide-Docetaxel Ver 1.1
Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL Regimen Breast Cancer – Cyclophosphamide-Docetaxel Indication Adjuvant therapy for early breast cancer when anthracyclines are
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelVer11.pdf
Capecitabine-Lapatinib
Description
Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Cancer – Capecitabine-Lapatinib Indication • Treatment of locally advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf
Pembrolizumab(400mg)
Description
Chemotherapy Protocol COLORECTAL CANCER Pembrolizumab (400mg) Regimen • Colorectal – Pembrolizumab (400mg) Indication • Pembrolizumab is recommended in in adult patients with metastatic colorectal
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Pembrolizumab400mg.pdf
Capecitabine-Oxaliplatin 4-cycles
Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and OXALIPLATIN (CAPOX-4 cycles) Regimen • Colorectal Cancer – Capecitabine-Oxaliplatin 4 cycles (CAPOX-4 cycles) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Oxaliplatin-4-cycles.pdf
Docetaxel-Pertuzumab/TrastuzumabSC
Description
Chemotherapy Protocol BREAST CANCER Docetaxel-Pertuzumab/Trastuzumab SC Regimen • Breast Cancer – Docetaxel-Pertuzumab/Trastuzumab SC Indication • Treatment of metastatic breast cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-PertuzumabTrastuzumabSC.pdf
Cetuximab-Encorafenib
Description
Chemotherapy Protocol COLORECTAL CANCER CETUXIMAB-ENCORAFENIB Regimen • Colorectal Cancer – Cetuximab-Encorafenib Indication • Cetuximab and encorafenib can be used where; - the patient
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Cetuximab-Encorafenib.pdf
501
to
510
of
630
Previous
…
49
50
51
52
53
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.